A carregar...
Long-Term Pharmacological Management of Phenylketonuria, Including Patients Below the Age of 4 Years
BH4 therapy is an advancement in the treatment of phenylketonuria, reducing blood phenylalanine (phe) levels and increasing tolerance to natural proteins of responding patients. We report the results of 16 patients undergoing long-term BH4 treatment. Responding patients to BH4 was usually based on 2...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer Berlin Heidelberg
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3509844/ https://ncbi.nlm.nih.gov/pubmed/23430859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_53 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|